Physician profile
Yazan Abdeen
NPI 1679983605
$44,044.74
in general payments reported to CMS, 2019-2025
37 companies · $1,429 in 2025
The $1,429 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $5,794 · 2021: $54.69 · 2022: $3,117 · 2023: $2,193 · 2024: $2,386 · 2025: $1,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,709 · Travel and Lodging: $2,242 · Education: $57.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,709.32 |
| Travel and Lodging | $2,241.62 |
| Education | $57.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $23,848.83 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Grifols USA, LLC | $4,882.22 | 2019 | |
| Viiv Healthcare Company | $3,400.00 | 2019 | |
| Intuitive Surgical, INC. | $3,000.00 | 2022 | |
| Inari Medical, INC. | $1,861.37 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Noah Medical Corporation | $1,078.64 | 2023 | |
| Olympus Corporation of The Americas | $1,038.47 | 2019 | |
| Boston Scientific Corporation | $725.94 | 2019 | |
| Electromed, INC. | $685.73 | 2023-2025 | Smartvest |
| Ethicon INC. | $552.17 | 2019 | |
| Inspire Medical Systems, INC. | $411.18 | 2024-2025 | Inspire |
| Genzyme Corporation | $353.92 | 2024-2025 | |
| Abbvie INC. | $279.15 | 2023-2025 | Teflaro |
| Astrazeneca Pharmaceuticals LP | $250.71 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Actelion Pharmaceuticals US, INC. | $229.06 | 2019 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yazan Abdeen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.